Clinical Trial Update: Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports superior efficacy of Dymista (azelastine hydrochloride and fluticasone propionate nasal spray) in treating seasonal alle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• DYMISTA (azelastine hydrochloride and fluticasone propionate)

Snippet

Sponsor: University of Chicago | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2024-10-17